 |
|
|
|
 |
|
|
|
|
|
|
Department
|
Hematology/Oncology
|
|
Hospital Title
|
Director, Hematology Clinic; Clinical Director, Sickle Cell Program
|
|
Academic Title
|
Instructor of Pediatrics
|
|
Phone
|
617-355-7700
|
|
Fax
|
617-730-0641
|
|
Email
|
Matthew Heeney
|
|
Location
|
300 Longwood Avenue
Boston MA 02115
|
 |
 |
|
|
|
|
|
|
|
Dr. Heeney conducts clinical research focused on sickle cell disorders and their treatment. He is currently the Principal Investigator of several studies at Children's Hospital Boston, including the Children's Hospital Clinical Core of the Boston Comprehensive Sickle Cell Center, one of ten NIH sponsored Comprehensive Sickle Cell Centers. Dr. Heeney is also interested in iron homeostasis in humans. He is beginning to investigate the possible genetic basis of iron resistant iron deficiency in several related kindreds.
Goals of Dr. Heeney's work include: to improve the understanding of the pathophysiology and treatment of sickle cell anemia through multicenter clinical trials and the Comprehensive Sickle Cell Centers network; and to elucidate the genetic basis of iron resistant iron deficiency in several related kindreds.
|
|
|
|
|
|
Dr. Heeney received his MD at the University of Calgary, Alberta, completed his residency at Montreal Children's Hospital, McGill University, and a pediatric hemotology/oncology fellowship at Duke University.
|
|
|
|
|
- Heeney MM. Howard TA. Zimmerman SA. Ware RE. UGT1A Promoter Polymorphisms Influence Bilirubin Response Hydroxyurea Therapy in Sickle Cell Anemia. Journal of Laboratory and Clinical Medicine. 141(4): 279-282, 2003.
- Heeney MM. Whorton MR. Howard TA. Johnson CA. Ware RE. Chemical and Functional Analysis of Hydroxyurea Oral Solutions. Journal of Pediatric Hematology/Oncology. 26 (3): 179-184, 2004.
- Heeney MM. Andrews NC. Iron Homeostasis and Inherited Iron Overload Disorders: An overview. Hematology/Oncology Clinics of North America. 18(6): 1379-403, 2004.
|
|
|
|
|
|
|
|
|
|
|
